Article Information
History
- December 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Helen Ashwin1,#,
- Luke Milross2,#,
- Julie Wilson3,#,
- Joaquim Majo4,
- Jimmy Tsz Hang Lee5,
- Grant Calder6,
- Bethany Hunter2,
- Sally James6,
- Dimitris Lagos1,
- Nathalie Signoret1,
- Andrew Filby7,
- Omer Ali Bayraktar5,
- Andrew J. Fisher2,8,* and
- Paul M. Kaye1,*
- 1York Biomedical Research Institute, Hull York Medical School, University of York, York, UK
- 2Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK
- 3Department of Mathematics, University of York, York, UK
- 4Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
- 5Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK
- 6Biosciences Technology Facility, University of York, York, UK
- 7Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK
- 8Institute of Transplantation, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
- ↵*Correspondence to: a.j.fisher{at}newcastle.ac.uk or paul.kaye{at}york.ac.uk
↵# HA, LM and JW contributed equally to the work
Posted December 13, 2022.
Identification of a protein expression signature distinguishing early from organising diffuse alveolar damage in COVID-19 patients
